CTRI/2022/09/046069
Not yet recruiting
Phase 3
A controlled clinical study to evaluate the efficacy of Jatyadighrita suppository in post operative pain management of Anorectal disorders
Dr SRINIVASA N V0 sites0 target enrollmentTBD
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Health Condition 1: T889- Complication of surgical and medical care, unspecified
- Sponsor
- Dr SRINIVASA N V
- Status
- Not yet recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\) Patients undergoing fissurectomy, hemorrhoidectomy, fistulotomy.
- •2\) Patients between the age group of 20 to 60 years were included in the study
Exclusion Criteria
- •1\. Fissure/hemorrhoid/fistula in ano with Inflammatory Bowel Disease and Crohns disease.
- •2\. Patients suffering from systemic diseases like DM, Tuberculosis, Rheumatoid arthritis.
- •3\. Positive cases for Human Immunodeficiency Virus (HIV), Venereal Disease Research Laboratory (VDRL) and hepatitis\-B
- •4\. The post operative cases with complications like severe bleeding, Wound sepsis.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 2
Avabahuka management through ayurvedaHealth Condition 1: M958- Other specified acquired deformities of musculoskeletal systemCTRI/2024/03/063989Pt Khushilal Sharma Government Autonomous Ayurveda College and Institute Bhopal MP
Not yet recruiting
Phase 3
A comparitive clinical study of povidine ointment and Vranaropani malahara on fresh woundCTRI/2024/07/069772Dr Surender Redhu
Completed
Phase 2
management of plantar fasciitis by ayurvedic kwath iontophoresisHealth Condition 1: M709- Unspecified soft tissue disorder related to use, overuse and pressureCTRI/2021/05/033429All India Institute of Ayurveda25
Not yet recruiting
Phase 2
A clinical study to evaluate the efficacy of Nirgundi taila and Nirgundi malahara in the management of Fissure-in-anoCTRI/2023/12/060815Dr Hari R
Recruiting
Not Applicable
Clinical study on the treatment of asymptomatic and mild patients with COVID-19 by Tibetan MedicineITMCTR2200006549Tibetan Hospital Mentsee Khang of Tibet Autonomous Region